Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone.
作者： Peter J. Weiden , David G. Daniel , George Simpson , Steven J. Romano
DOI: 10.1097/01.JCP.0000095347.32154.08
关键词: Olanzapine 、 Side effect 、 Risperidone 、 Internal medicine 、 Ziprasidone 、 Psychiatry 、 Schizophrenia 、 Tolerability 、 Weight loss 、 Medicine 、 Antipsychotic
摘要: … with acute exacerbation of schizophrenia and schizoaffective … the “weight neutrality” of ziprasidone, as seen in long-term … of ziprasidone therapy in stable outpatients with schizophrenia …
lww.com
sci-hub.se 参考文章(7)
Donald C. Goff, Thomas Posever, Lawrence Herz, Jeffrey Simmons, Nicholas Kletti, Katherine Lapierre, Keith D. Wilner, C. Gordon Law, Grant N. Ko, An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder Journal of Clinical Psychopharmacology. ,vol. 18, pp. 296- 304 ,(1998) , 10.1097/00004714-199808000-00009
D Daniel, Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder: A 6-Week Placebo-Controlled Trial Neuropsychopharmacology. ,vol. 20, pp. 491- 505 ,(1999) , 10.1016/S0893-133X(98)00090-6
R DICKSON, Neuroleptic-induced hyperprolactinemia Schizophrenia Research. ,vol. 35, ,(1999) , 10.1016/S0920-9964(98)00159-5
Steven J. Kingsbury, Mohamed Fayek, Dorina Trufasiu, Jaafar Zada, George M. Simpson, The apparent effects of ziprasidone on plasma lipids and glucose. The Journal of Clinical Psychiatry. ,vol. 62, pp. 347- 349 ,(2001) , 10.4088/JCP.V62N0507
P. Keck Jr, Alan Buffenstein, James Ferguson, John Feighner, William Jaffe, Edmund P. Harrigan, Marilyn R. Morrissey, Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial Psychopharmacology. ,vol. 140, pp. 173- 184 ,(1998) , 10.1007/S002130050755
Peter J. Weiden, George M. Simpson, Steven G. Potkin, Richard L. O’Sullivan, Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia. The Journal of Clinical Psychiatry. ,vol. 64, pp. 580- 588 ,(2003) , 10.4088/JCP.V64N0514
Joseph C. Cappelleri, Janet L. Mentore, Ming C. Infante, Linda P. Chandler, David B. Allison, Moonseong Heo, Peter J. Weiden, Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis American Journal of Psychiatry. ,vol. 156, pp. 1686- 1696 ,(1999) , 10.1176/AJP.156.11.1686